LAS VEGAS, Dec. 19 /PRNewswire/ -- Nevada Cancer Institute (NVCI) President Heather Murren today announced Nicholas J. Vogelzang, M.D., a nationally-recognized leader in oncology research, as the institute’s first director. As director, Dr. Vogelzang will set the direction and recruit leaders for NVCI’s research programs in clinical, basic, and population science.
“We are thrilled to have recruited a researcher and medical oncologist of Dr. Vogelzang’s stature and reputation,” said Heather Murren, president of NVCI. “Not only are his credentials and experience impeccable, he also has the entrepreneurial spirit, compassion and integrity necessary to help us build a comprehensive, world-class cancer effort for the state of Nevada.”
Prior to joining NVCI, Dr. Vogelzang was the director of the University of Chicago Cancer Research Center. In this role, Dr. Vogelzang was responsible for coordinating the overall scientific direction of the university and its role within the local medical community. The University of Chicago Cancer Research Center is a National Cancer Institute designated Clinical Cancer Center. Dr. Vogelzang’s primary focus as a physician-researcher is in clinical trials for genitourinary malignancies and mesothelioma. He is a recognized expert in new therapies for patients with metastatic kidney cancer, including genetic therapy, new cytokine therapy, and combination cytokine therapy. He also conducts large-scale national trials in the field of prostate cancer and mesothelioma.
Dr. Vogelzang received his M.D. degree from the University of Illinois at Chicago and completed residency at Rush-Presbyterian-St. Luke’s Medical Center in Chicago.
For more information on NVCI, please visit http://www.nevadacancerinstitute.org/. For images, please contact Heather Harvey 702-821-0024.
The Nevada Cancer Institute is a non-profit 501(c) (3) and is the official cancer institute of Nevada. The institute is dedicated to the detection, prevention and treatment of cancer. NVCI has steadfastly resolved to change the state’s cancer statistics by creating a world-class cancer care center offering all cancer patients, regardless of their economic status, state-of-the-art treatment and comprehensive cancer care. As the only state cancer effort to receive federal funding in 2003, NVCI is building upon Nevada’s existing resources by linking the University of Nevada School of Medicine, University of Nevada, Reno and University of Nevada, Las Vegas under the institute umbrella.
Nevada Cancer Institute
CONTACT: Heather Harvey of Nevada Cancer Institute, +1-702-821-0024, orcell, +1-702-303-3634, or hharvey@nevadacancerinstitute.org
Web site: http://www.nevadacancerinstitute.org/
